Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Friday, April 2, 2010

MeBO-Biolab gut dysbiosis study : tester 5 organic acid result back

Tester 5 was our 'thorough' tester, who did a greater number of tests than the standard MeBO-Biolab gut dysbiosis study, in the hope of shining some more light on the problem of systemic body odors. Her full list of results can be seen in a previous post.

It took longer than anticipated to get her organic acid test result back, but it seems to show no obvious issues. The organic acid test chosen was not as thorough as we would have liked, but factors such as cost and accessibility played a big part. Our ideal starting point for testing would be a urine test looking for 'malodorous volatile organic compounds', but we have not found a source for this test. Also a DNA test of all the xenobiotic metabolizing enzymes (including FMO3) would seem appropriate, but this would be quite expensive.

The test included 3-hydroxy-isovaleric acid, which can be an indicator for biotin deficiency and has been reported as being high in systemic body odor cases anecdotally.



Anyone wishing to participate in the MeBO-Biolab gut dysbiosis study can do so by filling out the questionaire. It would cost you £170 to do all 5 tests. The tests chosen were to look at certain gut dysbiosis markers, as well as Vitamin B2 levels (B2 is a cofactor in proper FMO3 function). The tests should be seen as a starting point in looking for answers to systemic body odors. Of particular interest is the 'ethanol' test, which is regarded as a test of yeast gut overgrowth. So far, quite a few of our testers have been positive for this.

0 comments:

Post a Comment